Immunotherapy for the treatment of cancer has always had great promise; unfortunately, the return on the time and money invested has been very disappointing (cost Goodman the head of MMSK many years ago; he didn't cure cancer nor did he balance the budget ). Time will tell whether this approach pans out but certainly some very interesting research studies: